This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Comparing Coherus' Cimerli anti-VEGF with Lucentis in treating Wet AMD
Ticker(s): CHRS, RHHBYWho's the expert?
An ophthalmologist who treats patients with wet-AMD
Interview GoalThis conversation will focus on the use of Lucentis in treating wet-AMD and where Cimerli could fit in.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
